Navigation Links
Healthnostics' Medbioworld.com Portal Web Site to Include Social Networking Features
Date:10/7/2009

NEW YORK, Oct. 7 /PRNewswire-FirstCall/ - Healthnostics, Inc. (OTC PK: HNSS), a medical and biotechnology analytics company, announced today details regarding the social networking features of their MedBioWorld Web Portal under re-design. Using the Facebook(C) model that gives individuals greater power to share and connect, MedBioWorld will build an interactive layer that allows users to comment and establish a presence to share and access biomedical information.

MedBioWorld is expanding its rich biomedical content already available to its professional customer base to include a more general audience. Providing this new audience with the means to interact with professional level content should lead to an increased rate of user return and the viral spread of site awareness. The user experience will be further enhanced by providing biomedical-based widgets and other mini-applications that will attract larger audiences and deliver user profiles related to site usage for increased content targeting and topic specific development.

"Integrating the user in an active, participatory way is critical to user growth for the MedBioWorld site," said Alan Grofe, president. "A social networking approach to user involvement will help us focus our newly expanded user base on biomedical information that is not only trusted and relevant, but is also entertaining."

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics' major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld(TM), one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

CONTACT: Alan Grofe, P. (703) 754-7126

SOURCE Healthnostics, Inc.


'/>"/>
SOURCE Healthnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Healthnostics Unveils Biomedical Content Strategy for Medbioworld.com
2. Web Portal Makes Organ Donation Easy
3. CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution
4. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
5. Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal
6. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
7. University of Michigan Installs Neuro Kinetics I-Portal(R) NOTC System
8. First-Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U.S.
9. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
10. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
11. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):